Aciclovir + Hydrocortisone
important information for the patient.
This medicine should always be used exactly as described in the package leaflet for the patient or as advised by
the doctor, pharmacist, or nurse.
Zovirax Duo contains two active substances: aciclovir and hydrocortisone. Aciclovir acts
against viruses and helps fight the virus that causes cold sores. Hydrocortisone is a mild
steroid that reduces the inflammation associated with cold sores.
Zovirax Duo cream is used to treat the early signs of cold sores and skin around the mouth (such as tingling, itching, or redness), to reduce the risk of developing cold sores into blisters in adults and adolescents aged 12 and over.
Even if the cold sore has already developed into blisters, using Zovirax Duo reduces the healing time of the sores by about half a day to one day, compared to a cream that does not contain active ingredients.
Cold sores are caused by the herpes simplex virus. This virus causes the formation of blisters and ulcers, mainly on the lips, but also on other parts of the face. Cold sores can develop when the body's immune system is weakened, e.g., during a cold or other infection. Stress, strong sunlight, low temperatures, or menstruation can also trigger cold sores.
If symptoms persist for 5 days after the end of treatment, the patient should consult their doctor.
Zovirax Duo should only be used on cold sores and skin around the mouth.
The patient should talk to their doctor if they have severe, recurring cold sores to check if they have any other health problems.
Zovirax Duo should not be used:
Hands should be washed before and after applying the cream to avoid worsening the symptoms
of the disease or transferring it to others.
If the patient experiences blurred vision or other vision disturbances, they should contact their doctor.
Zovirax Duo should not be used for more than 5 days.
This medicine should not be used in children under 12 years of age, as its efficacy and safety in this age group are not known.
The patient should tell their doctor about all medicines they are currently taking or have recently taken, as well as any medicines they plan to take, including those available without a prescription.
It is not known whether the action of Zovirax Duo may change if the patient is taking other medicines at the same time.
The cream should not be applied immediately before eating, as it may be licked off in this situation.
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult their doctor or pharmacist before using this medicine.
Zovirax Duo should not be used during pregnancy and breastfeeding unless the doctor considers that the benefit to the mother outweighs the unknown risk.
Zovirax Duo does not affect the ability to drive and use machines.
This medicine contains 200 mg of propylene glycol.
Cetearyl alcohol may cause local skin reactions (e.g., contact dermatitis).
The medicine contains 8 mg of sodium lauryl sulfate.
Sodium lauryl sulfate may cause local skin reactions (such as stinging or burning) or may exacerbate skin reactions caused by other products applied to the same area.
This medicine should always be used exactly as described in the package leaflet for the patient or as advised by
the doctor, pharmacist, or nurse.
In case of doubt, the patient should consult their doctor or pharmacist.
Zovirax Duo is for external use only.
A higher dose than recommended should not be used.
The cream should be applied 5 times a day for 5 days (on average every 3-4 hours during the day). Treatment should be started as soon as possible, preferably after the first signs of a cold sore (such as tingling, redness, or itching).
The cream should not be used for more than 5 days.
The patient should consult their doctor if the symptoms of the cold sore persist for more than 5 days after the end of treatment.
Hands should be washed before and after applying the cream to avoid worsening the cold sore or infecting another person.
If an ulcer develops, the area should not be touched more often than necessary to avoid transferring the infection to other parts of the body or to the eyes.
If the patient accidentally uses too much cream or swallows it, it is unlikely to cause any health problems. However, if a large amount of cream is swallowed, the patient should consult their doctor.
In case of doubts about the use of this medicine, the patient should consult their doctor or pharmacist.
If a dose is missed, the patient should apply the cream as soon as they remember and then continue treatment as before.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
The patient should stop using the medicine and consult their doctor immediately if they experience any of the following symptoms of an allergic reaction (very rare side effects: may occur less frequently than in 1 in 10,000 patients):
The following side effects are listed in order of their likelihood:
Common: may occur in up to 1 in 10 people
Uncommon: may occur in up to 1 in 100 people
Rare: may occur in up to 1 in 1,000 patients
Unknown:
If the patient experiences any side effects, including any possible side effects not listed in the leaflet, they should inform their doctor or pharmacist.
If the patient experiences any side effects, including any possible side effects not listed in the leaflet, they should inform their doctor, pharmacist, or nurse. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: +48 22 49 21 301, fax: +48 22 49 21
The medicine should be stored out of sight and reach of children.
Store at a temperature below 25°C. Do not store in the refrigerator or freeze.
Do not use this medicine after the expiry date stated on the carton and tube after “EXP” or “Expiry Date”. The expiry date refers to the last day of the month.
Shelf life after first opening the tube: 3 months.
Do not use this medicine if its appearance and/or consistency have changed.
Medicines should not be disposed of via wastewater or household waste. The patient should ask their pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
Zovirax Duo is a white to yellowish cream.
The pack contains an aluminum tube or an aluminum tube laminated with HDPE, containing 2 g of cream, placed in a cardboard box.
Haleon Poland Sp. z o.o.
ul. Rzymowskiego 53
02-697 Warsaw
tel. 800 702 849
Haleon Germany GmbH
Barthstraße 4
80339 Munich
Germany
Haleon Denmark ApS
Delta Park 37, 2665, Vallensbæk Strand
Denmark
Haleon Belgium NV,
Da Vincilaan 5,
1930 Zaventem,
Belgium
Haleon - Gebro Consumer Healthcare GmbH
Bahnhofbichi 13, 6391 Fieberbrunn
Austria
Zovirax Duo:
Belgium, Bulgaria, Croatia, Czech Republic, Estonia, Netherlands, Ireland, Luxembourg,
Latvia, Germany, Poland, Portugal, Romania, Slovakia, Hungary
Zoviduo:
Cyprus, Denmark, Finland, Greece, Spain, Iceland, Lithuania, Malta, Norway,
Slovenia, Sweden, Italy
Activir Duo:
Austria
Detailed information on this medicine is available on the website of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products.
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.